Alcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio.
One drop works to significantly reduce redness, with results lasting up to 12 hours1Lasts up to 50% longer than Lumify1-2,*Expands Alcon's portfolio of consumer eye care solutions and will be available in major
Alcon got permission to sell a new eye drop that reduces redness. This shows the company is growing its regular eye care business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.